Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Nicole Massoll

Concepts (210)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Nodule
5
2022
31
1.160
Why?
Thyroid Neoplasms
8
2022
112
1.120
Why?
Biopsy, Fine-Needle
7
2024
108
0.610
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2008
59
0.520
Why?
Uterus
2
2008
85
0.520
Why?
Papillomavirus Infections
2
2008
168
0.460
Why?
Carcinoma, Papillary
3
2017
47
0.460
Why?
Breast Neoplasms
6
2018
1201
0.380
Why?
Vulvar Neoplasms
3
2008
58
0.360
Why?
Carcinoma, Squamous Cell
4
2008
326
0.350
Why?
MicroRNAs
3
2022
344
0.320
Why?
Cysts
2
2006
51
0.320
Why?
Uterine Cervical Neoplasms
2
2008
276
0.290
Why?
Uterine Cervical Dysplasia
1
2008
49
0.290
Why?
Precancerous Conditions
1
2008
82
0.290
Why?
Carcinoma, Lobular
1
2007
33
0.270
Why?
Cytological Techniques
1
2006
14
0.270
Why?
Carcinoma, Ductal, Breast
1
2007
91
0.260
Why?
Adenomyoma
1
2005
2
0.250
Why?
Neoplasms, Hormone-Dependent
1
2005
8
0.250
Why?
Carcinoma in Situ
2
2008
73
0.250
Why?
Gynecologic Surgical Procedures
1
2005
29
0.240
Why?
Biopsy, Needle
1
2006
178
0.240
Why?
Focal Adhesion Protein-Tyrosine Kinases
3
2010
20
0.240
Why?
Uterine Neoplasms
1
2005
60
0.240
Why?
Lymph Nodes
3
2017
257
0.240
Why?
Competency-Based Education
1
2024
28
0.230
Why?
Carcinoma, Medullary
1
2004
12
0.230
Why?
Fellowships and Scholarships
1
2024
120
0.210
Why?
Mastectomy
2
2018
142
0.210
Why?
Humans
31
2024
50503
0.200
Why?
Clinical Competence
1
2024
398
0.190
Why?
Pathology
3
2024
38
0.180
Why?
Focal Adhesion Kinase 1
2
2012
15
0.180
Why?
Female
20
2020
27081
0.180
Why?
Diagnostic Tests, Routine
1
2020
28
0.180
Why?
Carcinoma, Neuroendocrine
1
2020
23
0.180
Why?
Diagnosis, Differential
4
2008
1033
0.180
Why?
Mutation
6
2022
1280
0.170
Why?
Lung Neoplasms
2
2015
601
0.160
Why?
DNA, Neoplasm
2
2018
143
0.160
Why?
Protein Kinase Inhibitors
2
2012
204
0.160
Why?
Proto-Oncogene Proteins B-raf
2
2017
80
0.160
Why?
Immunohistochemistry
6
2015
957
0.150
Why?
Thyroid Gland
3
2020
75
0.140
Why?
Pancreatic Neoplasms
2
2010
206
0.140
Why?
Gene Silencing
2
2008
115
0.140
Why?
Middle Aged
10
2020
12611
0.130
Why?
Neoplasm Invasiveness
5
2015
269
0.130
Why?
DNA, Viral
2
2008
136
0.130
Why?
Fibroblasts
2
2016
336
0.130
Why?
PTEN Phosphohydrolase
1
2016
53
0.130
Why?
Pulmonary Medicine
1
2015
15
0.130
Why?
Cytodiagnosis
1
2015
41
0.120
Why?
Cell Proliferation
4
2016
985
0.120
Why?
Sensitivity and Specificity
3
2020
859
0.120
Why?
Endosonography
1
2015
94
0.120
Why?
Adult
9
2020
13577
0.120
Why?
Lymphatic Metastasis
3
2017
222
0.110
Why?
Aged, 80 and over
5
2020
3226
0.110
Why?
Receptor, erbB-2
2
2018
75
0.100
Why?
Laryngeal Diseases
1
2013
12
0.100
Why?
Herpes Simplex
1
2013
21
0.100
Why?
Laryngectomy
1
2013
27
0.100
Why?
Purine Nucleosides
1
2012
3
0.100
Why?
Receptor, IGF Type 1
1
2012
20
0.100
Why?
Immunoenzyme Techniques
2
2008
137
0.090
Why?
Predictive Value of Tests
2
2020
930
0.090
Why?
Receptors, Somatomedin
1
2010
8
0.090
Why?
Vascular Endothelial Growth Factor Receptor-3
1
2009
5
0.080
Why?
Tissue Fixation
2
2020
34
0.080
Why?
Aniline Compounds
1
2009
43
0.080
Why?
Retrospective Studies
5
2022
6263
0.080
Why?
Melanoma
1
2012
280
0.080
Why?
Fluorescent Antibody Technique, Direct
1
2008
3
0.080
Why?
Cell Movement
1
2009
247
0.080
Why?
Neuroblastoma
1
2008
51
0.070
Why?
Transglutaminases
1
2008
15
0.070
Why?
Aged
5
2020
9741
0.070
Why?
Biopsy
2
2007
588
0.070
Why?
Mastitis
1
2007
3
0.070
Why?
Genetic Markers
1
2008
104
0.070
Why?
GTP-Binding Proteins
1
2008
91
0.070
Why?
Genes, erbB-2
1
2007
8
0.070
Why?
Prednisone
1
2007
101
0.070
Why?
Granuloma
1
2007
45
0.070
Why?
Gene Expression Regulation, Enzymologic
1
2008
179
0.070
Why?
Group Practice
1
2006
3
0.070
Why?
Cystatins
1
2006
1
0.070
Why?
Cadherins
1
2007
63
0.070
Why?
Frozen Sections
1
2006
13
0.070
Why?
Genomic Instability
1
2007
90
0.070
Why?
Specialization
1
2006
46
0.070
Why?
Colonic Neoplasms
1
2008
158
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2008
572
0.070
Why?
Tumor Suppressor Protein p53
1
2008
213
0.070
Why?
Medicine
1
2006
56
0.060
Why?
RNA, Small Interfering
3
2012
208
0.060
Why?
Promoter Regions, Genetic
1
2008
465
0.060
Why?
Antigens, CD
1
2007
222
0.060
Why?
Gene Expression
1
2008
610
0.060
Why?
Mullerian Ducts
1
2005
4
0.060
Why?
Fallopian Tubes
1
2005
22
0.060
Why?
Medical Oncology
1
2006
98
0.060
Why?
Signal Transduction
1
2012
1624
0.060
Why?
Chromosome Aberrations
1
2007
280
0.060
Why?
Data Collection
1
2006
280
0.060
Why?
Vulva
1
2005
17
0.060
Why?
ABO Blood-Group System
1
2005
15
0.060
Why?
Glucocorticoids
1
2007
230
0.060
Why?
Estrogen Replacement Therapy
1
2005
41
0.060
Why?
Ovariectomy
1
2005
115
0.060
Why?
Hysterectomy
1
2005
88
0.060
Why?
Mice, Nude
3
2010
248
0.060
Why?
Decision Making
1
2007
272
0.060
Why?
Carcinoma, Transitional Cell
1
2005
51
0.060
Why?
Regression Analysis
1
2006
382
0.060
Why?
Epithelial Cells
1
2006
207
0.060
Why?
Papillomaviridae
1
2005
103
0.060
Why?
Cell Survival
3
2012
589
0.060
Why?
Epigenesis, Genetic
1
2008
372
0.060
Why?
Cell Line, Tumor
4
2009
1398
0.060
Why?
Mice
5
2017
5687
0.060
Why?
Cohort Studies
2
2020
1452
0.060
Why?
Ultrasonography
1
2006
435
0.060
Why?
Polymerase Chain Reaction
1
2005
449
0.060
Why?
Male
6
2020
25907
0.050
Why?
Base Sequence
3
2010
639
0.050
Why?
Prospective Studies
2
2022
2378
0.050
Why?
Education, Medical, Graduate
1
2024
217
0.050
Why?
Gene Expression Profiling
1
2007
1025
0.050
Why?
Formaldehyde
1
2020
49
0.040
Why?
Oncogenes
1
2020
57
0.040
Why?
Adolescent
2
2015
6443
0.040
Why?
Neoplasm Staging
2
2015
746
0.040
Why?
Transplantation, Heterologous
2
2010
75
0.040
Why?
Antineoplastic Agents
1
2008
1172
0.040
Why?
Animals
5
2017
13124
0.040
Why?
Blotting, Western
2
2012
578
0.040
Why?
DNA Primers
2
2010
206
0.040
Why?
Young Adult
2
2020
4102
0.040
Why?
Paraffin Embedding
1
2018
51
0.040
Why?
Specimen Handling
1
2018
55
0.040
Why?
Receptors, Progesterone
1
2018
64
0.040
Why?
Receptors, Estrogen
1
2018
132
0.040
Why?
Methylene Blue
1
2017
9
0.040
Why?
Lymphatic System
1
2017
13
0.040
Why?
Animals, Genetically Modified
1
2017
48
0.030
Why?
Coloring Agents
1
2017
66
0.030
Why?
Mice, Inbred Strains
1
2017
160
0.030
Why?
Prognosis
2
2015
1978
0.030
Why?
Follow-Up Studies
2
2015
2242
0.030
Why?
Treatment Outcome
1
2006
5283
0.030
Why?
Cost Savings
1
2015
57
0.030
Why?
Apoptosis
2
2012
1097
0.030
Why?
Neoplasm Grading
1
2015
122
0.030
Why?
RNA, Messenger
2
2008
1089
0.030
Why?
Collagen
1
2016
204
0.030
Why?
Cost-Benefit Analysis
1
2015
266
0.030
Why?
Disease Progression
2
2008
829
0.030
Why?
Tumor Microenvironment
1
2016
222
0.030
Why?
DNA Methylation
2
2008
550
0.030
Why?
Immunoprecipitation
1
2012
59
0.030
Why?
In Situ Nick-End Labeling
1
2012
52
0.030
Why?
Flow Cytometry
1
2012
474
0.020
Why?
Cell Line
1
2012
988
0.020
Why?
Staurosporine
1
2009
12
0.020
Why?
Deoxycytidine
1
2009
30
0.020
Why?
Drug Synergism
1
2009
151
0.020
Why?
Cell Adhesion
1
2009
157
0.020
Why?
RNA Interference
1
2009
178
0.020
Why?
Xenograft Model Antitumor Assays
1
2009
212
0.020
Why?
Polymorphism, Single-Stranded Conformational
1
2008
18
0.020
Why?
Chromatin Immunoprecipitation
1
2008
48
0.020
Why?
Luciferases
1
2008
49
0.020
Why?
Adenoviridae
1
2008
48
0.020
Why?
Florida
1
2008
58
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
67
0.020
Why?
Fluorouracil
1
2008
58
0.020
Why?
Loss of Heterozygosity
1
2008
75
0.020
Why?
Phosphorylation
1
2009
525
0.020
Why?
Electrophoresis, Polyacrylamide Gel
1
2008
98
0.020
Why?
Transcriptional Activation
1
2008
119
0.020
Why?
Estrogens
1
2009
226
0.020
Why?
Drug Screening Assays, Antitumor
1
2008
131
0.020
Why?
Transfection
1
2008
356
0.020
Why?
Enzyme Inhibitors
1
2009
377
0.020
Why?
Ultrasonography, Mammary
1
2007
61
0.020
Why?
Kaplan-Meier Estimate
1
2008
464
0.020
Why?
Transcription, Genetic
1
2008
361
0.020
Why?
Molecular Sequence Data
1
2008
778
0.020
Why?
Cystatin M
1
2006
19
0.020
Why?
5' Untranslated Regions
1
2006
25
0.020
Why?
RNA, Neoplasm
1
2006
43
0.020
Why?
Cesarean Section
1
2007
157
0.020
Why?
Survival Rate
1
2008
909
0.020
Why?
Mice, Knockout
1
2008
844
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2009
833
0.020
Why?
Chi-Square Distribution
1
2005
277
0.010
Why?
Cells, Cultured
1
2008
1571
0.010
Why?
Neoplasm Recurrence, Local
1
2008
629
0.010
Why?
Pregnancy Complications
1
2007
380
0.010
Why?
Tomography, X-Ray Computed
1
2007
1164
0.010
Why?
Infant, Newborn
1
2008
2749
0.010
Why?
Magnetic Resonance Imaging
1
2007
1548
0.010
Why?
Pregnancy
1
2007
2452
0.010
Why?
Infant
1
2008
3628
0.010
Why?
Child, Preschool
1
2008
3942
0.010
Why?
Risk Factors
1
2008
3724
0.010
Why?
Child
1
2008
6906
0.010
Why?
Massoll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description